Background
==========

Depression, a common and chronic disorder, is characterized by specific symptoms, with an estimated prevalence of around 4--5% in middle to late adolescence \[[@b1-medscimonit-25-7459]--[@b3-medscimonit-25-7459]\]. According to the World Health Organization, depression is projected to become the leading cause of global disease by 2030 \[[@b4-medscimonit-25-7459],[@b5-medscimonit-25-7459]\]. Almost a quarter of all adults will experience depression beginning in adolescence \[[@b6-medscimonit-25-7459]\]. Depression in adolescents can have devastating outcomes, including poor educational attainment, impaired social relationships, insomnia, smoking, substance misuse, and obesity \[[@b7-medscimonit-25-7459]--[@b10-medscimonit-25-7459]\]. More than half of suicide victims in adolescents had depressive disorder, making depression the most common cause of suicide \[[@b11-medscimonit-25-7459]\]. As depression is a national public health problem, it is urgent to prevent its onset and recurrence in this vulnerable population by recognizing and treating this disorder \[[@b12-medscimonit-25-7459],[@b13-medscimonit-25-7459]\].

Many studies have associated mental health with region, race, cultural setting, and socioeconomic status \[[@b14-medscimonit-25-7459],[@b15-medscimonit-25-7459]\]. Owing to different cultures and beliefs, Canadian teenagers have lower prevalence of depressive symptoms than their counterparts in China \[[@b16-medscimonit-25-7459]\]. During the past 2 decades, China has had sharp economic growth and entered into a dramatic transition of economy and society. Therefore, Chinese people must accordingly change their lifestyles and accelerate their pace of life to adapt to the transition. As a result, numerous risk factors appeared and increased in daily life, such as enormous emotional pressure and weakening of social support \[[@b17-medscimonit-25-7459],[@b18-medscimonit-25-7459]\].

Although many studies have evaluated depressive symptoms among teenagers in China, the results widely varied across studies, ranging from 4.41% \[[@b19-medscimonit-25-7459]\] to 55.7% \[[@b20-medscimonit-25-7459]\]. This inconsistency is probably caused by differences in sample sizes and screening tools with diverse cutoffs \[[@b21-medscimonit-25-7459]\]. For instance, the prevalence of depressive symptoms assessed using CES-D (Center for Epidemiological Studies Depression) as a screening instrument with different cutoffs varies from 5.6% \[[@b22-medscimonit-25-7459]\] to 54.4% \[[@b23-medscimonit-25-7459]\]. In consideration of these inconsistencies and in light of the many negative outcomes of depression, it is imperative to estimate the prevalence of depressive symptoms to design effective preventive strategies aimed at this vulnerable age group.

A recent systematic review and meta-analysis summarized the prevalence of depressive symptom in China, but included only middle school students \[[@b24-medscimonit-25-7459]\]. While some studies reported that the prevalence estimates of depression start to grow in early adolescence, we also included children in this analysis. The association between the reported prevalence of depressive symptoms and the year of study publication was also explored in this meta-analysis, and we also analyzed the trend of depressive symptoms among children and adolescents in China in the last 30 years.

Material and Methods
====================

Our study was conducted following the framework of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) \[[@b25-medscimonit-25-7459]\]. The quality assessment instrument for epidemiological studies was applied when assessing the quality of studies \[[@b26-medscimonit-25-7459]--[@b28-medscimonit-25-7459]\]. All analyses were based on previously published studies; therefore, ethics approval and patient consent were not required.

Search strategies
-----------------

We conducted a comprehensive literature search to identify published research on the prevalence of depressive symptom among children and adolescents in China. The 5 major electronic databases -- the CNKI database (China National Knowledge Infrastructure), the Wan Fang database, Cochrane CENTRAL, PubMed, and EMBASE -- were searched to find all eligible articles. Medical subject headings \[MeSH\] and keywords combined with Boolean operators were used in the search strategy to look for relevant studies published between 1988 and 2018, and the following MeSH terms were used: "child\*", "teenager\*", "adolescent\*", "student\*", "depressive symptoms\*", "depression\*", "prevalence\*", "rate\*". The bibliographies and citations of relevant articles and review studies were also screened for other potential articles.

Inclusion and exclusion criteria
--------------------------------

All the eligible studies in this meta-analysis were subjected to the following inclusion criteria: (1) cross-sectional study of depressive symptom about child and adolescence aged less than 18 years old; (2) depressive symptom as the major outcome of eligible articles was clearly identified by self-report scales that previous studies have demonstrated with validated psychometric properties; (3) prevalence statistics on depressive symptoms can be calculated in accordance with the relevant article; (4) the full-text article could be retrieved through different computerized databases; and (5) sample size greater than 200 individuals.

The following publications were excluded from this meta-analysis: (1) published reviews, conference abstracts, and opinion pieces or commentaries only presented with abstract; (2) studies with a sample population including undergraduates, patients, or groups who had a special vocation; (3) if there were multiple results emerging from the same cross-sectional dataset, only data from the paper with the largest sample size and the most stringent screening criteria was included; and (4) depressive symptoms were measured using the self-edited scales with no demonstrated psychometric properties. In the event of ambiguity, any differences at each stage were resolved by consensus and the involvement of another experienced expert (YX). [Figure 1](#f1-medscimonit-25-7459){ref-type="fig"} demonstrates the selection process of this meta-analysis.

Data extraction
---------------

The same group of reviewers independently screened the title and abstracts. According to the inclusion and exclusion criteria, 2 reviewers assessed all the eligible studies that could be retrieved from the academic database. Data items were extracted by the first author (JYL) from relevant articles using a standardized data collection sheet developed by the previous review, which included the surname of the first author, publication year, demographic characteristic, sample size, the prevalence of depressive symptoms, and the number of cases of depression reported in the primary studies or other subgroup variables (e.g., scales, gender, and grades). Then, the results were double-checked by the second author (JL). To acquire missing information of relevant studies, the corresponding authors were contacted.

Quality assessment
------------------

The quality of each study was assessed by the quality assessment instrument for epidemiological studies \[[@b26-medscimonit-25-7459]--[@b28-medscimonit-25-7459]\]. The instrument was applied to evaluate all included studies with the following 8 items: (1) the target population was clearly defined; (2) the sample was obtained through probability sampling methods; (3) having a representative sample; (4) non-responders were clearly described; (5) the response rate was great than 80% \[[@b29-medscimonit-25-7459]\]; (6) having standardized data collection methods; (7) having good psychometrics measures to evaluate depressive symptoms; and (8) having confidence intervals for statistical estimates. Consistent with previous studies, articles were summed to give a total score out of 8, with each item assigned a score of 1 ("Yes") or 0 ("No"). Discrepancies in scores of included studies were resolved through discussion to reach consensus.

Statistical analyses
--------------------

Stata version 12.0 (Stata Corp, College Station, TX) was used for all statistical analyses. The pooled prevalence of depressive symptoms estimates was based on the random-effects model, which gave an overall estimate across studies weighted by sample size, with the assumption of statistical heterogeneity among studies \[[@b30-medscimonit-25-7459],[@b31-medscimonit-25-7459]\]. The magnitude of heterogeneity across studies was estimated using the I^2^ statistic, which shows the proportion of total variation of all included studies due to heterogeneity rather than change. The interpretation of I^2^ values shows that 25%, 50%, and 75% indicate low, moderate, and high heterogeneity, respectively \[[@b32-medscimonit-25-7459]\]. We calculated the pooled effect sizes, along with their respective 95% confidence intervals (CI). Subgroup analysis was conducted to explore potential moderating factors for heterogeneity, stratified by region, gender, grade, year of publication, and scales combined with cutoffs. We performed meta-regressions to identify the association of prevalence of depressive symptom with year of publication. Publication bias was examined by adjusted-comparison funnel plot symmetry, and Egger's test was used to test the stability of the inverse funnel plot \[[@b33-medscimonit-25-7459],[@b34-medscimonit-25-7459]\].

Results
=======

Study characteristics
---------------------

We initially identified 5437 articles through the search of 5 academic databases, of which 4136 were assessed after duplications were removed. Of these, 1057 remained after screening of titles and abstracts. On review of the full text, 62 papers that met the inclusion criteria were finally included in analysis. Of the 995 excluded articles, 359 did not provide prevalence estimates of depressive symptoms, 389 studies lacked validated screening tools, 87 studies lacked required items, 76 studies were commentary, editorial, or review, 62 studies reported the same population, and 22 articles did not include the full text. [Figure 1](#f1-medscimonit-25-7459){ref-type="fig"} shows a flowchart of the selection process. [Table 1](#t1-medscimonit-25-7459){ref-type="table"} summarizes the characteristics of all included studies. In these 62 studies, 232 586 children and adolescents were involved and the sample size ranged from 300 to 47 863. The year of publication covered a time span of 27 years, which ranged from 1991 to 2018. Of these 62 included studies, 8 different self-report rating systems were used in our analysis.

Prevalence of depressive symptoms in children and adolescents
-------------------------------------------------------------

The prevalence of depressive symptoms of all the included studies were described in [Table 1](#t1-medscimonit-25-7459){ref-type="table"}, ranging from 4.41% to 55.7% in individual studies. The overall pooled prevalence of depressive symptoms in children and adolescents was 22.2% (95% CI: 19.9--24.6%, I^2^=99.6%, p\<0.001), showing significant heterogeneity among studies.

Subgroup analyses and meta-regression
-------------------------------------

The results of meta-analyses stratified by date of publication and screening tool are summarized in [Table 2](#t2-medscimonit-25-7459){ref-type="table"}. There were significant differences in the prevalence of depressive symptom by year of publication. The date of publication was divided into 5 sections. Five studies were published before 2000, the pooled prevalence of which was estimated as 18.4% (95% CI, 14.5--22.3%; I^2^=91.3%). Eight studies were published between 2001 and 2005, the pooled prevalence of which was estimated as 25.4% (95% CI, 17.6--33.3%; I^2^=99.5%). Nine studies were published between 2006 and 2010, the pooled prevalence of which was estimated as 18.0% (95% CI, 13.9--22.3%; I^2^=98.4%). Twenty-one studies were published between 2011 and 2015, the pooled prevalence of which was estimated as 20.1% (95% CI, 16.5--23.6%; I^2^=99.2%). Nineteen studies were published after 2016, the pooled prevalence of which was estimated as 26.3% (95% CI, 21.9--30.8%; I^2^=99.8%). [Table 3](#t3-medscimonit-25-7459){ref-type="table"} shows that the prevalence of depressive symptoms generally increased over time, while the meta-regression analysis showed that this trend was not associated with year of publication (I^2^=99.6%, p=0.30). The pooled prevalence of depressive symptoms was lowest with SCL-90 (cutoff ≥2, 10.3%; p\<0.001) and highest with CESD-10 (cutoff ≥8, 54.5%; p\<0.001). Participants with a higher grade showed greater risk of depressive symptoms: primary school, 17.5% (95% CI, 14.0--21.1%); junior secondary school, 21.9% (95% CI, 18.7--25.1%); and senior secondary school, 24.2% (95% CI, 19.9--28.6%). Nevertheless, meta-regression analysis revealed that grade was not associated with the prevalence of depressive symptoms (I^2^=99.1%, p=0.07). Females (22.3%; 95% CI, 19.5--25.0%) had a higher risk of depression than males (21.4%; 95% CI, 18.6--24.1%). Adolescents from rural areas (28.6%; 95% CI, 22.1--35.1%) had an obviously greater prevalence than these from urban areas (22.9%; 95% CI, 17.8--28.1%). Significant heterogeneity (I^2^ greater than 85%) was observed within these variables.

Sensitivity analysis
--------------------

Sensitivity analysis, conducted by omitting each study in succession in each group, showed that no individual study significantly influenced the primary results.

Publication bias
----------------

Significant asymmetry was visually observed in the funnel plot ([Figure 2](#f2-medscimonit-25-7459){ref-type="fig"}). Egger's test (p\<0.05) showed there were substantial publication bias in this analysis.

Discussion
==========

This systematic review and meta-analysis of 62 original studies involving 232 586 children and adolescents suggest that between 10.3% and 54.5% of adolescents screened positive for depression. The pooled prevalence in depressive symptom among children and adolescents in China was 22.2%, and these findings are reinforced by previous relevant meta-analyses \[[@b24-medscimonit-25-7459]\].

Some studies have demonstrated that depression in adolescence is associated with higher risk of recurrent depressive episodes in adulthood \[[@b93-medscimonit-25-7459]\] and increased comorbidity during adult life \[[@b94-medscimonit-25-7459]\]. Since adolescent suffering from depression may commit suicide, making depression the second-to-third primary cause of death in this population \[[@b95-medscimonit-25-7459]\], more effective interventions needed to be carried out early to prevent such tragedy. Adolescence is an extremely significant period for the building of personality and development of life skills. Once the process is interfered with depression during this period, a number of negative outcomes, such as dropping out of school, substance abuse, and unemployment, become more likely to occur throughout the lifespan \[[@b96-medscimonit-25-7459],[@b97-medscimonit-25-7459]\]. Thus, this analysis highlights an urgent issue for children and adolescents.

In this analysis, the pooled prevalence estimate was higher than in 6 previous studies among teenagers in China \[[@b98-medscimonit-25-7459]--[@b103-medscimonit-25-7459]\]. When compared with other countries -- 16.6% in Australia \[[@b104-medscimonit-25-7459]\], 4.28% in Greece \[[@b105-medscimonit-25-7459]\], 10.6% in Italy \[[@b106-medscimonit-25-7459]\], and 17.3% in Korea \[[@b107-medscimonit-25-7459]\] -- this study also demonstrated a greater estimated prevalence of depressive symptoms. Previous research by Tang et al. \[[@b24-medscimonit-25-7459]\] reported that the prevalence of depressive symptom was 24.3%, which is higher than the result in our analysis. This difference is likely mainly due to a larger sample size of participants covering a wider age range in the present study, which included primary school students, middle school students, and high school students. With regard to the cause of depression, which is a severe mental problem among youth, substantial research has been conducted to identify risk factors associated with depression, such as genetic risk (e.g., offspring of parents with depression) \[[@b108-medscimonit-25-7459]\], family factors (e.g., family discord and poverty) \[[@b109-medscimonit-25-7459]\], and stressful life events (e.g., academic pressure and interpersonal pressure) \[[@b110-medscimonit-25-7459]\]. Although there are myriad risk factors facing youth, effective interventions aimed at depression, especially the early onset of depressive symptoms, are relatively scarce in China.

When stratified by year of publication and divided into 5 periods, the prevalence estimates of depressive symptoms were highest in the last period. [Table 3](#t3-medscimonit-25-7459){ref-type="table"} shows that the prevalence of depressive symptoms is positively associated with year of publication as a whole, but the difference was not significant in meta-regression analysis. The foremost reason for this association is that the quantity of studies involved in this article varied among different periods; there were fewer studies in the 1990s and more in the 2010s, which to some extent reflects an increased awareness of depression among Chinese researchers. Meanwhile, the rapid development of the society and economy in China likely contributes to mental health problems in children and adolescents. Under these circumstances, some studies reported that depression is becoming the most common concern of Chinese teenagers \[[@b111-medscimonit-25-7459]\].

The prevalence estimates were closely linked to grade in the present study, which is consistent with a previous review \[[@b24-medscimonit-25-7459]\]. Some possible explanations for this phenomenon identified by previous studies are tremendous academic pressure of entrance examinations, neurobiological changes, and increased interpersonal problems \[[@b112-medscimonit-25-7459]\].

In the current study, 8 self-report rating scales with different cutoffs were included. The result revealed that a significant difference in the summary prevalence estimates existed among different screening tools, which was a major source of heterogeneity. Nevertheless, the prevalence estimates of epidemiological studies usually varied with screening instruments, samples, and survey methods \[[@b113-medscimonit-25-7459]\]. Although this heterogeneity was unavoidable, screening scales with strong psychometric properties and identified cutoffs should be taken into consideration during the initial design, thus making it possible to make direct comparison with other countries.

In terms of gender, there were slight differences in the summary prevalence estimates in this study: 22.3% for females and 21.4% for males. Some researches associated maturation of the hypothalamic-pituitary-adrenal (HPA) axis and endocrine systems with gender differences in depressive symptoms \[[@b13-medscimonit-25-7459],[@b114-medscimonit-25-7459]\]. In addition, our results were not in line with previous meta-analyses based on nationally representative samples \[[@b115-medscimonit-25-7459]\], which reported that the OR (odds ratio) value between prevalence of depression in females and males was 2. It revealed that gender differences in depressive symptoms generally appeared among adolescents at the age of 12 years old and continued during puberty. The wide age range in our study may have narrowed the gender difference.

We found that children from rural areas had a significantly higher prevalence of depressive symptoms that children from urban areas (26.2% versus 27.5%, respectively). This result was consistent with many previous reports \[[@b116-medscimonit-25-7459],[@b117-medscimonit-25-7459]\], indicating that relative poverty, lack of social support, and low income status are linked to high prevalence in depressive symptoms among children.

Several strengths of the present meta-analysis should be noted. There were 62 primary studies involving a large pooled sample size in this study, which provided greater statistical power. In addition, we conducted a complete search on both Chinese databases and English databases, generating a comprehensive coverage. However, our findings also have important limitations. Economic and social development is highly uneven among provinces in China, and our study did not cover all the provinces, which to some extent limits generalizability of the results. Secondly, the majority of studies used school-based samples, and thus might be more prone to selection bias, although it is widely accepted that surveys conducted in schools are about as accurate as those conducted in the community setting \[[@b118-medscimonit-25-7459]\]. Thirdly, although subgroup analyses aimed at publication years combined with other variables were performed to overcome the substantial heterogeneity, the problem remained in this meta-analysis of epidemiological studies \[[@b119-medscimonit-25-7459]\].

Conclusions
===========

The trend of prevalence of depressive symptoms among Chinese children and adolescents as a whole has increased in the last 3 decades. Our findings could be useful to policy makers and service commissioners to better understand depressive symptom, a notable problem facing children and adolescents. Given that depressive symptoms can begin at an early age, be recurrent, and are associated with more poor outcomes, we emphasized mental health services and effective interventions for children and adolescents.
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###### 

Characteristics of the 62 studies of depressive symptoms in the meta-analysis.

  Author (s) (year)                                    Province              Grades   Scale     Cutoffs   ESS     Case   Prevalence (%)   Quality score
  ---------------------------------------------------- --------------------- -------- --------- --------- ------- ------ ---------------- ---------------
  Liu et al. (1991) \[[@b35-medscimonit-25-7459]\]     Shandong              J        SDS       ≥50       537     135    25.14            4
  lu et al. (1999) \[[@b36-medscimonit-25-7459]\]      Shandong              J,S      CES-D     ≥20       800     186    23.25            5
  Zhou et al. (2000) \[[@b37-medscimonit-25-7459]\]    Jiangsu               J        SCL-90    ≥2        726     110    15.15            5
  Yuan et al. (2000) \[[@b38-medscimonit-25-7459]\]    Anhui                 S        CES-D     ≥20       3157    512    22.5             4
  Mai et al. (2000) \[[@b39-medscimonit-25-7459]\]     Guangdong             J,S      SCL-90    ≥3        330     41     12.42            5
  Zhang et al. (2001) \[[@b40-medscimonit-25-7459]\]   Anhui                 J,S      CES-D     ≥20       12430   2834   22.8             5
  Zhang et al. (2001) \[[@b41-medscimonit-25-7459]\]   Multiple Cities       J,S      SCL-90    ≥2        912     51     5.6              5
  Cui et al. (2002) \[[@b42-medscimonit-25-7459]\]     Anhui                 J        SDS       ≥41       331     104    31.42            4
  Su et al. (2002) \[[@b43-medscimonit-25-7459]\]      Anhui                 S        Beck      ≥5        1902    805    45.5             4
  Tang et al. (2003) \[[@b44-medscimonit-25-7459]\]    Hunan                 P        DSRSC     ≥15       565     97     17.17            4
  Duan et al. (2004) \[[@b45-medscimonit-25-7459]\]    Beijing               J,S      PHI       ≥60       5910    1584   26.8             5
  Sun et al. (2005) \[[@b46-medscimonit-25-7459]\]     Tianjin               P,J      DSRSC     ≥14       516     78     15.1             4
  Feng et al. (2005) \[[@b47-medscimonit-25-7459]\]    Sichuan & Chongqing   J,S      Beck      ≥5        2634    1115   42.3             5
  Shu et al. (2006) \[[@b48-medscimonit-25-7459]\]     Guangdong             J        CDI       ≥19       300     33     11               3
  Xu et al. (2006) \[[@b49-medscimonit-25-7459]\]      Jiangsu               J,S      CDI       ≥20       7161    1060   14.8             5
  Gu et al. (2007) \[[@b50-medscimonit-25-7459]\]      Hebei                 P        DSRSC     ≥15       522     94     18.01            4
  Zhang et al. (2007) \[[@b51-medscimonit-25-7459]\]   Anhui                 J        CES-D     ≥16       4524    1201   26.5             5
  Xu et al. (2008) \[[@b52-medscimonit-25-7459]\]      Anhui & Guangdong     P        CDI       ≥19       3224    341    10.6             5
  Hong et al. (2009) \[[@b53-medscimonit-25-7459]\]    Jiangsu               J        CDI       ≥20       2444    384    15.7             5
  Li et al. (2009) \[[@b54-medscimonit-25-7459]\]      Guizhou               S        SDS       ≥50       2352    336    14.3             5
  Liu et al. (2009) \[[@b55-medscimonit-25-7459]\]     Guangdong             P        CDI       ≥19       667     112    16.5             4
  Li et al. (2010) \[[@b56-medscimonit-25-7459]\]      Henan                 P,J      CES-D     ≥16       755     261    34.57            4
  Cao et al. (2011) \[[@b57-medscimonit-25-7459]\]     Anhui                 J,S      DSRSC     ≥15       5003    1191   23.8             5
  Liu et al. (2012) \[[@b58-medscimonit-25-7459]\]     Beijing               J,S      CES-D     ≥16       1175    354    30.1             4
  Peng et al. (2012) \[[@b59-medscimonit-25-7459]\]    Sichuan               S1       CES-D     ≥31       5544    800    14.4             5
  Jia et al. (2012) \[[@b60-medscimonit-25-7459]\]     Yunnan                J,S      CES-D     ≥20       7979    1802   22.6             5
  Zhang et al. (2012) \[[@b61-medscimonit-25-7459]\]   Shanxi                J,S      DSRSC     ≥15       2363    545    23.1             5
  Shan et al. (2013) \[[@b62-medscimonit-25-7459]\]    Shanghai              J,S      CES-D     ≥16       2761    767    27.8             5
  Chang et al. (2013) \[[@b63-medscimonit-25-7459]\]   Shanghai              P,J      CES-D     ≥16       1250    494    39.5             3
  Luo et al. (2013) \[[@b64-medscimonit-25-7459]\]     Heilongjiang          P,J      DSRSC     ≥15       1535    223    14.5             3
  Hu et al. (2013) \[[@b65-medscimonit-25-7459]\]      Gansu                 P        CES-D     ≥16       623     119    19.1             4
  Liang et al. (2013) \[[@b66-medscimonit-25-7459]\]   Guangdong             J,S      CDI       ≥19       1087    205    18.86            4
  Zhu et al. (2013) \[[@b67-medscimonit-25-7459]\]     Hubei                 P,J,S    CDI       ≥19       1975    269    13.6             4
  Chang et al. (2013) \[[@b19-medscimonit-25-7459]\]   Jiangsu               P        DSRSC     ≥15       749     33     4.41             3
  Guo et al. (2014) \[[@b68-medscimonit-25-7459]\]     Henan                 J,S      CES-DC    ≥29       1774    426    24               4
  Zhang et al. (2014) \[[@b69-medscimonit-25-7459]\]   Zhejiang              J,S      DSRSC     ≥15       1939    334    17.23            4
  Guo et al. (2014) \[[@b70-medscimonit-25-7459]\]     Guangdong             J,S      CES-D     ≥28       3186    205    6.4              5
  Shen et al. (2015) \[[@b71-medscimonit-25-7459]\]    Hubei                 J,S      CDI       ≥20       2283    281    12.6             4
  Wu et al. (2015) \[[@b72-medscimonit-25-7459]\]      Beijing               P        CDI       ≥12       1472    457    31.04            3
  Wu et al. (2015) \[[@b73-medscimonit-25-7459]\]      Guangdong             J,S      CES-D     ≥28       3042    307    10.1             4
  Guo et al. (2015) \[[@b74-medscimonit-25-7459]\]     Shanghai              P,J      CDI       ≥19       950     135    14.21            4
  Wang et al. (2015) \[[@b75-medscimonit-25-7459]\]    Guangdong             S        SDS       ≥53       1121    464    41.4             4
  Wang et al. (2015) \[[@b76-medscimonit-25-7459]\]    Henan                 P,J,S    CDI       ≥19       3002    430    14.3             5
  Guo et al. (2016) \[[@b22-medscimonit-25-7459]\]     Multiple Cities       J,S      CES-D     ≥28       35893   2017   5.6              5
  Tan et al. (2016) \[[@b23-medscimonit-25-7459]\]     Guangdong             J        CESD-10   ≥8        1661    905    54.4             4
  Zhu et al. (2016) \[[@b77-medscimonit-25-7459]\]     Hainan                P,J      CDI       ≥19       4866    1573   32.3             4
  Xie et al. (2016) \[[@b78-medscimonit-25-7459]\]     Hubei                 P,J,S    CDI       ≥19       2888    412    14.3             4
  Liu et al. (2016) \[[@b79-medscimonit-25-7459]\]     Anhui                 S        CES-D     ≥20       2768    1339   48.4             4
  Ding et al. (2017) \[[@b80-medscimonit-25-7459]\]    Hubei                 P,J,S    CES-D     ≥16       6406    1041   16.3             4
  Li et al. (2017) \[[@b81-medscimonit-25-7459]\]      Guangdong             J        CES-D     ≥16       1015    238    23.4             3
  Jia et al. (2017) \[[@b20-medscimonit-25-7459]\]     Shanghai              S        Beck      ≥5        928     517    55.7             3
  Zou et al. (2017) \[[@b82-medscimonit-25-7459]\]     Shandong              J,S      CES-D     ≥16       492     200    40.7             3
  Wu et al. (2017) \[[@b83-medscimonit-25-7459]\]      Zhejiang              J,S      CDI       ≥20       2000    250    12.5             4
  Zhang et al. (2017) \[[@b84-medscimonit-25-7459]\]   Henan                 J,S      CES-D     ≥20       1343    269    20.03            4
  Zhang et al. (2018) \[[@b85-medscimonit-25-7459]\]   Hubei                 P,J,S    CES-D     ≥16       5793    739    16.2             5
  Zhou et al. (2018) \[[@b86-medscimonit-25-7459]\]    Multiple Cities       P,J      CES-D     ≥17       2679    544    20.3             4
  Zhang et al. (2018) \[[@b87-medscimonit-25-7459]\]   Zhejiang              J,S      BDI-II    ≥14       3264    949    29.08            4
  Liu et al. (2018) \[[@b88-medscimonit-25-7459]\]     Xinjiang              P,J      CDI       ≥19       3610    1195   33.1             4
  Peng et al. (2018) \[[@b89-medscimonit-25-7459]\]    Chongqing             P,J      CDI       ≥19       3351    841    25.1             4
  Ji et al. (2018) \[[@b90-medscimonit-25-7459]\]      Multiple Cities       P,J,S    CES-D     ≥28       47863   5570   11.6             6
  Qu et al. (2018) \[[@b91-medscimonit-25-7459]\]      Xinjiang              J        SDS       ≥53       1335    465    34.8             4
  Lin et al. (2018) \[[@b92-medscimonit-25-7459]\]     Xinjiang              P        CDI       ≥19       919     103    11.2             4

ESS -- effective sample size; P -- primary school; J -- junior high school; S -- senior high school; SDS -- Zung Self-Rating Depression Scale; CDI -- Children's Depression Inventory; CES-D -- Center for Epidemiological Studies Depression; SCL-90 -- The Symptom Checklist subscales for depression; DSRSC -- Depression Self-Rating Scale for Children; BDI-II -- Beck Depression Inventory-II; Beck -- Beck Depression Inventory; PHI -- Psychological Health Inventory.

###### 

Subgroup analyses of the prevalence of depressive symptoms.

  Subgroup           Categories    No. of studies   Total No. of participants   Number of cases   Prevalence (%)   95% CI           I^2^ (% with P-value)
  ------------------ ------------- ---------------- --------------------------- ----------------- ---------------- ---------------- -----------------------
  Scales             Beck                                                                                                           
   ≥5                3             5464             2437                        46.7              39.4--53.9       96.4 (\<0.001)   
  BDI-II                                                                                                                            
   ≥14               1             3264             949                         29.1              27.5--30.6                        
  CDI                                                                                                                               
   ≥12               1             1472             457                         31.0              28.7--33.4                        
   ≥19               7             23615            5308                        18.7              13.5--23.8       99.0 (\<0.001)   
   ≥20               5             17112            2316                        13.2              11.3--15.1       92.3 (\<0.001)   
  CES-D                                                                                                                             
   ≥8                1             1661             905                         54.5              52.1--56.9                        
   ≥16               11            27473            5958                        26.3              21.5--31.1       98.9 (\<0.001)   
   ≥20               6             28477            6942                        25.5              18.7--32.3       99.4 (\<0.001)   
   ≥29               5             91758            8525                        11.4              7.7--15.2        99.7 (\<0.001)   
   ≥32               1             5544             800                         14.4              13.5--15.4                        
  DSRSC                                                                                                                             
   ≥15               8             13192            2595                        16.7              11.3--15.1       98.5 (\<0.001)   
  PHI                                                                                                                               
   ≥60               1             5910             1584                        26.8              25.7--27.9                        
  SCL-90                                                                                                                            
   ≥2                2             1638             161                         10.3              0.9--19.7        97.4 (\<0.001)   
   ≥3                1             330              41                          12.4              8.9--16.0                         
  SDS                                                                                                                               
   ≥41               1             331              104                         31.4              26.4--36.4                        
   ≥50               2             2889             471                         19.6              8.9--30.2        96.6 (\<0.001)   
   ≥53               2             2456             929                         38.1              31.6--44.5       91.0 (\<0.001)   
  Publication year   Before 2000   5                5550                        984               18.4             14.5--22.3       91.3 (\<0.001)
  2001--2005         8             25200            6668                        25.4              17.6--33.3       99.5 (\<0.001)   
  2006--2010         9             21949            3822                        18.0              13.9--22.0       98.4 (\<0.001)   
  2011--2015         21            50813            9841                        20.1              16.5--23.6       99.2 (\<0.001)   
  After 2016         19            129074           19167                       26.3              21.9--30.8       99.8 (\<0.001)   
  Grades             P             19               41007                       5753              17.5             14.0--21.1       98.9 (\<0.001)
  J                  31            63561            12857                       21.9              18.7--25.1       99.1 (\<0.001)   
  S                  23            45725            9682                        24.2              19.9--28.6       99.3 (\<0.001)   
  Gender             Male          46               97085                       16210             21.4             18.6--24.1       99.4 (\<0.001)
  Female             46            97076            16021                       22.3              19.5--25.0       99.3 (\<0.001)   
  Region             Rural         13               23858                       6097              22.9             17.8--28.1       98.9 (\<0.001)
  Urban              13            22283            5151                        28.6              22.1--35.1       99.3 (\<0.001)   

###### 

The forest plot of depressive symptoms based on publication year.
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